Oct 15, 2025 21:45
PPCB - Propanc Biopharma, Inc. Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 1.79 -0.05 (-2.79%) | --- | -0.01 (-0.51%) | 0.03 (1.75%) | -0.02 (-1.07%) | -0.04 (-2.26%) | 0.04 (2.35%) | 0.04 (2.35%) |
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Closed
Earnings & Ratios
- Basic EPS:
- Diluted EPS:
- Basic P/E:
- Diluted P/E:
- RSI(14) 1m:
- 81.25
- VWAP:
- 1.74
- RVol:
- 3.593
Events
| Period | Kind | Movement | Occurred At |
|---|---|---|---|
| 1m | Price increase 1m | 1.88 +0.05 (+2.73%) | Oct 15 10:39 |
| 1m | Price decrease 1m | 1.85 -0.04 (-2.11%) | Oct 15 10:34 |
| 60m | Price increase 60m | 1.9 +0.1 (+5.56%) | Oct 15 10:31 |
| 1m | Price increase 1m | 1.9 +0.02 (+1.33%) | Oct 15 10:31 |
| 1m | Price decrease 1m | 1.85 -0.02 (-1.07%) | Oct 15 10:30 |
Related News
Aug 19, 2025 12:30
Aug 15, 2025 03:00